Incretins, insulin secretion and Type 2 diabetes mellitus
Tina Vilsbøll(University of Copenhagen), Jens J. Holst(University of Copenhagen)
Cited by 438
Related Papers
Semaglutide, reduction in glycated haemoglobin and the risk of diabetic retinopathy
|Diabetes Obesity and Metabolism|2017|290
Benefits and Harms of Sodium-Glucose Co-Transporter 2 Inhibitors in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis
|PLoS ONE|2016|241
Incretin hormones and the satiation signal
|International Journal of Obesity|2013|187
No direct effect of SGLT2 activity on glucagon secretion
|Diabetologia|2019|73